Literature DB >> 23624887

A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease.

Charles N Bernstein1, Siew C Ng, Peter L Lakatos, Bjorn Moum, Edward V Loftus.   

Abstract

Standardized mortality rates in ulcerative colitis (UC) are no different than that in the general population. Patients who are older and have more comorbidities have increased mortality. Emergent colectomy still carries 30-day mortality rates of approximately 5%. In more recent studies, UC surgery rates at 10 years from diagnosis are nearly 3% in Hungary, <10% in referral center studies from Asia, approximately 10% in Norway, the European Cohort Study of Inflammatory Bowel Diseases and Manitoba, Canada, and nearly 17% in Olmsted County, Minnesota. These rates are for the most part lower than reported colectomy rates from studies completed before 1990. Short-term colectomy rates in severe hospitalized UC have remained stable at 27% for several years. Generally, children seem to have higher rates of extensive colitis at diagnosis than adults. There also seems to be higher rates of colectomy in children than in adults (i.e., at least 20% at 10 years), and perhaps, this reflects a higher rate of extensive disease. Acute severe colitis in patients with UC still represents a condition with a high early colectomy rate and a measurable mortality rate.

Entities:  

Mesh:

Year:  2013        PMID: 23624887     DOI: 10.1097/MIB.0b013e318281f3bb

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  37 in total

Review 1.  Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.

Authors:  Fanni Rencz; Márta Péntek; Martin Bortlik; Edyta Zagorowicz; Tibor Hlavaty; Andrzej Śliwczyński; Mihai M Diculescu; Limas Kupcinskas; Krisztina B Gecse; László Gulácsi; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

2.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

3.  Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.

Authors:  Niharika Nalagatla; Katherine Falloon; Gloria Tran; Nienke Z Borren; Danny Avalos; Jay Luther; Francis Colizzo; John Garber; Hamed Khalili; Joanna Melia; Matthew Bohm; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-23       Impact factor: 11.382

4.  Associations Between the Prognostic Nutritional Index and Morbidity/Mortality During Intestinal Resection in Patients with Ulcerative Colitis.

Authors:  Teruhiro Chohno; Motoi Uchino; Hirofumi Sasaki; Toshihiro Bando; Yoshio Takesue; Hiroki Ikeuchi
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

5.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

6.  Long non-coding RNA Mirt2 interacts with long non-coding RNA IFNG-AS1 to regulate ulcerative colitis.

Authors:  Chenyang Li; Lujia Cui; Siqiong Li; Minrui Li; Xinpu Miao
Journal:  Exp Ther Med       Date:  2020-09-01       Impact factor: 2.447

7.  Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.

Authors:  Gabriella Velonias; Grace Conway; Elizabeth Andrews; John J Garber; Hamed Khalili; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

Review 8.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.

Authors:  G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-02       Impact factor: 3.781

9.  Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.

Authors:  Dong Suk Shin; Jae Hee Cheon; Yong Eun Park; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2018-08-25       Impact factor: 3.199

10.  Fertility and Contraception in Women With Inflammatory Bowel Disease.

Authors:  Jason Martin; Sunanda V Kane; Linda A Feagins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.